“Rifaximin Versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients Having Cirrhosis of Liver”. Medical Forum Monthly 28, no. 12 (May 19, 2024). Accessed September 25, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/4304.